July 3, 2024

Aptamer Group signs agreement with AstraZeneca to explore Optimer delivery vehicles

Aptamer Group plc has partnered with AstraZeneca to evaluate Optimer® binders for targeted siRNA delivery to fibrotic liver cells, aiming to innovate gene therapies...

Baltic Classifieds Group Reports revenue grew 19% to €72.1 million, Full Year Results

Baltic Classifieds Group PLC (LON:BCG) reports solid growth with a 19% revenue increase to €72.1 million and a 20% rise in EBITDA for the year ending April 2024...

Syncona portfolio company Beacon Therapeutics raises $170 million in a Series B financing

Syncona Ltd (LON:SYNC) commits $42.5 million to Beacon Therapeutics' $170 million Series B financing to advance treatments for blinding retinal diseases...

GSK and CureVac to restructure collaboration into new licensing agreement

GSK plc and CureVac N.V. restructure their collaboration into a licensing agreement, enhancing mRNA vaccine development for influenza and COVID-19...
Search

Funds

XHR

Aptamer Group signs agreement with AstraZeneca to explore Optimer delivery vehicles

Aptamer Group plc has partnered with AstraZeneca to evaluate Optimer® binders for targeted siRNA delivery to fibrotic liver cells, aiming to innovate gene therapies...

Baltic Classifieds Group Reports revenue grew 19% to €72.1 million, Full Year Results

Baltic Classifieds Group PLC (LON:BCG) reports solid growth with a 19% revenue increase to €72.1 million and a 20% rise in EBITDA for the year ending April 2024...

Syncona portfolio company Beacon Therapeutics raises $170 million in a Series B financing

Syncona Ltd (LON:SYNC) commits $42.5 million to Beacon Therapeutics' $170 million Series B financing to advance treatments for blinding retinal diseases...

GSK and CureVac to restructure collaboration into new licensing agreement

GSK plc and CureVac N.V. restructure their collaboration into a licensing agreement, enhancing mRNA vaccine development for influenza and COVID-19...
Search

Funds

July 3, 2024

FTSE 100

Funds

Day: July 3, 2024